id="n_63">63
Scheer, F. & Buijs, R. (1999). Light affects morning salivary cortisol in humans. The Journal of Clinical Endocrinology & Metabolism 84 (9): 3395–3398.
64
Ryynänen, J. (2014). Pleiotropy of vitamin D-mediated gene regulation. Väitöskirja, Itä-Suomen yliopisto. [date of reference: 21.9.2014]
65
Loftas, T. et al. (1995). Dimensions of Need. An Atlas of Food and Agriculture. Food and Agriculture Organization of the United Nations.
66
Andrade, A. & Greene, G. & Melanson, K. (2008). Eating slowly led to decreases in energy intake within meals in healthy women. Journal of the Academy of Nutrition and Dietetics 108 (7): 1186–1191.
67
King, B. & Townsend-Nicholson, A. (2008). Involvement of P2Y1 and P2Y11 purinoceptors in parasympathetic inhibition of colonic smooth muscle. Journal of Pharmacology and Experimental Therapeutics 324 (3): 1055–1063.
68
Abels, J. et al. (1959). The physiologic mechanism of vitamin B12 absorption. Acta Medica Scandinavica 165: 105–113.
69
Kassarjian, Z. & Russell, R. (1989). Hypochlorhydria: a factor in nutrition. Annual Reviews Nutrition 9: 271–285. Review.
70
Lau, Y. & Ahmed, N. (2012). Fracture risk and bone mineral density reduction associated with proton pump inhibitors. Pharmacotherapy 32(1): 67–79.
71
Tennant, S. et al. (2008). Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infection and Immunity 76 (2): 639–645.
72
Sarzynski, E. & Puttarajappa, C. & Xie, Y. & Grover, M. & Laird-Fick, H. (2011). Association between proton pump inhibitor use and anemia: a retrospective cohort study. Digestive Diseases and Sciences 56 (8): 2349–2353.
73
Lam, J. & Schneider, J. & Zhao, W. & Corley, D. (2013). Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. The Journal of The American Medical Association 310 (22): 2435–2342.
74
Theisen, J. et al. (2000). Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. Journal of Gastrointestinal Surgery 4 (1): 50–54.
75
Helander, H. & Fändriks, L. (2014). Surface area of the digestive tract – revisited. Scandinavian Journal of Gastroenterology 49 (6): 681–689.
76
Irving, M. & Catchpole, B. (1992). ABC of colorectal diseases. Anatomy and physiology of the colon, rectum, and anus. British Medical Journal 304 (6834): 1106–1108. Review.
77
Miller, T. & Wolin, M. (1996). Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Applied and Environmental Microbiology 62 (5): 1589–1592.
78
А также ряд других биологически активных веществ, в том числе и мелатонин. – Прим. науч. ред.
79
Bollinger, R. et al. (2007). Biofilms in the large bowel suggest an apparent function of the human vermiform appendix. Journal of Theoretical Biology 249 (4): 826–831. Review.
80
Im, G. et al. (2011). The appendix may protect against Clostridium difficile recurrence. Clinical Gastroenterology and Hepatology 9 (12): 1072–1077.
81
Vons, C. et al. (2011). Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. The Lancet 377 (9777): 1573–1579.
82
Jussila, A. et al. (2013). High and increasing prevalence of inflammatory bowel disease in Finland with a clear North-South difference. Journal of Crohns & Colitis 7 (7): e256-262.
83
Hou, J. & Abraham, B. & El-Serag, H. (2011). Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. The American Journal of Gastroenterology 106 (4): 563-573. Review.
84
Среди исследователей нет единого мнения о значимости кишечной проницаемости для развития различных заболеваний. В настоящее время значимость синдрома leaky gut («дырявого кишечника») считается преувеличенной. – Прим. науч. ред.
85
Fasano, A. (2011). Leaky gut and autoimmune diseases. Clinical Reviews in Allergy and Immunology 42 (1): 71–78.
86
Olendzki, B. et al. (2014). An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutrition Journal 13: 5.
87
Drago, S. et al. (2006). Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scandinavian Journal of Gastroenterology 41 (4): 408–419.
88
Festen, E. et al. (2011) A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn’s disease
